Related Experiment Videos
Worksite influenza immunization programs. Insight into the implementation and cost-benefit
Geary W Olsen1, Marianne E Steinberg, Carol A Ley
13M Company, St. Paul, MN, USA.
Summary
Worksite influenza immunization programs offer significant economic benefits, with potential savings of $15-$50 per employee. These programs are feasible and recommended for employers due to cost-effectiveness and improved employee satisfaction.
Area of Science:
- Occupational Health
- Health Economics
- Vaccinology
Background:
- Worksite influenza immunization programs are crucial for public health and economic productivity.
- Assessing the return on investment for such programs requires careful consideration of multiple factors.
Purpose of the Study:
- To analyze the key determinants in cost-benefit analyses of worksite influenza immunization.
- To estimate the potential economic savings for employers offering these programs.
Main Methods:
- Review of existing literature and cost-benefit models for influenza immunization programs.
- Identification of critical variables including vaccine cost, administration, efficacy, and productivity loss estimations.
Main Results:
- Key factors influencing cost-benefit include vaccine expenses, administration, efficacy, and productivity loss assumptions.
- Estimated savings per healthy working adult employee range from $15 to $50.
- Variations in net savings are largely driven by employee productivity assumptions.
Conclusions:
- Efficient, large-scale worksite influenza immunization programs are practical and economically viable.
- Employers should consider these programs for both financial advantages and enhanced employee well-being and satisfaction.